Gut epithelial barrier and mucosa (GEB)

The gut epithelial barrier and mucosa represent a complex multi-layered system that serves as the primary interface between the external environment and the host's internal milieu. It consists of a physical barrier (mucus layer and epithelial cells connected by tight junctions), a chemical barrier (antimicrobial peptides and IgA), and an immunological barrier (gut-associated lymphoid tissue). Its primary biological function is to facilitate the selective absorption of nutrients and water while preventing the translocation of pathogens, toxins, and pro-inflammatory antigens into the systemic circulation (PMID: 33072128, StatPearls). Dysfunction of this barrier, often termed 'leaky gut,' is a central feature in the pathogenesis of various gastrointestinal and systemic inflammatory diseases, including Crohn's disease and ulcerative colitis (PMID: 28588585). Therapeutic strategies targeting this system aim to restore barrier integrity through the modulation of tight junction proteins like claudins and occludin, or by promoting mucosal healing via growth factors such as Glucagon-like peptide 2 (GLP-2) (PMID: 31243451). While not a single molecular target, it is a critical therapeutic focus for maintaining intestinal homeostasis and preventing chronic systemic inflammation.

Other names

Intestinal barrierGastrointestinal mucosal barrierIntestinal epithelial barrierGut barrierMucosal barrier

Drugs targeting the gut barrier typically work by stimulating epithelial cell proliferation (e.g., GLP-2 analogs), modulating tight junction assembly (e.g., zonulin antagonists), or reducing mucosal inflammation to allow for natural barrier repair (e.g., anti-TNF agents).